CN113786562A - Method and device for preventing recurrence of rhinitis treatment - Google Patents
Method and device for preventing recurrence of rhinitis treatment Download PDFInfo
- Publication number
- CN113786562A CN113786562A CN202111034685.8A CN202111034685A CN113786562A CN 113786562 A CN113786562 A CN 113786562A CN 202111034685 A CN202111034685 A CN 202111034685A CN 113786562 A CN113786562 A CN 113786562A
- Authority
- CN
- China
- Prior art keywords
- rhinitis
- nasal cavity
- data
- module
- nasal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/06—Quantitative determination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0607—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Radiology & Medical Imaging (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Medicinal Preparation (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
The invention provides a method and a device for preventing recurrence of rhinitis treatment, which can detect nasal discharge in a nasal cavity to obtain data of nasal cavity environment, then send the rhinitis state to a processor through an electric signal, analyze the sent electric signal to the greatest extent, compare the electric signal with the rhinitis data to obtain whether rhinitis occurs or not, control a laser component to start according to the electric signal, control the intensity of monochromatic light sent by a laser module according to the data obtained by signal comparison, further irradiate the inside of the nasal cavity through the sent light, simultaneously control a drug administration component to input drug liquid into the nasal cavity according to the signal, control the laser component to start according to the electric signal of nasal cavity data, control the intensity of the monochromatic light sent by the laser module according to the data obtained by signal comparison, further irradiate the inside of the nasal cavity through the sent light, further enable the power of the laser to be in direct proportion to the rhinitis degree, prevent the great damage to the nasal cavity caused by the laser power.
Description
Technical Field
The invention relates to the field of rhinitis instruments, in particular to a method and a device for preventing recurrence of rhinitis treatment.
Background
The rhinitis therapeutic instrument, treat diseases such as rhinitis, repair the damaged mucous membrane tissue, resume and improve nasal tissue and expel toxin metabolism and natural immunological competence, the thin liquid-like substance that the nasal cavity secretes is called nasal discharge or nasal secretion, its function is to help to clear away the dust, the bacterium keeps the health of the lung, when the nasal cavity presents inflammation, can secrete a large amount of nasal discharges in the nasal cavity, and can turn into yellow because of infecting, can cause the cough when flowing through the throat, the nasal discharge can also flow through the anterior nares when the nasal discharge is very much;
the existing rhinitis-treating principle is that low-intensity monochromatic laser with the wavelength of 650nm is adopted to irradiate the nasal cavity to stimulate sympathetic nerves and parasympathetic nerves in the nasal cavity, so that blood vessels of nasal mucosa can contract and expand, and meanwhile, a fat layer coated on the surface of red blood cells is rapidly peeled off to recover the permeability of red blood cell membranes, but rhinitis with different degrees needs stimulation with different high degrees, and when the stimulation is too large, the nasal cavity is damaged to aggravate the rhinitis.
SUMMARY OF THE PATENT FOR INVENTION
Aiming at the defects in the prior art, the invention provides a method and a device for preventing recurrence of rhinitis treatment, so as to improve the adaptability of hearing-impaired patients to noise environment.
According to a first aspect of the embodiments of the present disclosure, a preferred embodiment of the present invention provides a method for preventing recurrence of rhinitis treatment, comprising:
the nasal discharge in the nasal cavity is detected, so that the data of the nasal cavity environment are obtained, and then the rhinitis state is sent to a processor through an electric signal;
analyzing the sent electric signal, and comparing the electric signal with the rhinitis data to further obtain whether the rhinitis happens or not;
the laser component is controlled to start according to the electric signal, the intensity of monochromatic light emitted by the laser module is controlled according to data obtained by signal comparison, and then the interior of the nasal cavity is irradiated by the emitted light;
and simultaneously controls the drug administration component to input the liquid medicine into the nasal cavity according to the signal.
In one embodiment, the analyzing of the electric signal output by the detecting module is performed to compare the electric signal with rhinitis data, so as to determine whether rhinitis has occurred, wherein the rhinitis data includes content of bacteria in nasal discharge, amount of nasal discharge and types of human bacteria, and includes:
detecting the rhinorrhea through a bacteria detection module so as to obtain the content of specific weight bacteria;
and analyzing the obtained bacteria content data, and analyzing the types of the bacteria in the data.
In one embodiment, the analyzing the emitted electrical signal and comparing the electrical signal with the rhinitis data to determine whether the rhinitis has occurred includes:
calculating the content and species of the bacteria in the nasal discharge for a plurality of times;
calculating the average value of the bacterial content data of the previous time domain and the next time domain;
and comparing the average value with rhinitis data to further obtain whether the patient has rhinitis attack.
In one embodiment, said control laser part starts according to the electric signal, and the intensity of the monochromatic light that the module sent is controlled according to the data that the signal contrast reachs, and then shines the inside nasal cavity through the light that sends, include:
controlling the laser module to start according to the data analyzed by the processor;
the power of the laser module is controlled according to the severity of rhinitis, and the appropriate laser is controlled to stimulate the nasal cavity.
In one embodiment, the method comprises the following steps:
the detection module is used for acquiring nasal cavity data from nasal discharge in a nasal cavity environment;
the comparison module is used for carrying out comparison analysis on the acquired nasal cavity data and the rhinitis data so as to obtain a conclusion whether the rhinitis of the patient is in attack;
the laser module is used for emitting monochromatic light to stimulate sympathetic nerves and parasympathetic nerves in the nasal cavity, so that blood vessels of nasal mucosa can be contracted and expanded, meanwhile, a fat layer coated on the surface of red blood cells is rapidly peeled off, the permeability of red blood cell membranes is recovered, the red blood cells aggregated into clusters are dispersed, and the oxygen carrying capacity of the red blood cells is greatly improved; simultaneously activating multiple enzyme bodies in blood, and decomposing and ablating redundant fat in the blood; the disease resistance of the organism is improved; improving the toxic state of the organism, and protecting the organism from free radicals and other toxic substances;
and the drug delivery module is used for spraying the liquid medicine into the nasal cavity to repair the nasal mucosa at best.
In one embodiment, the detection module includes:
the acquisition module is used for acquiring the bacterial content and the bacterial species of the nasal discharge in the nasal cavity;
and the storage module is used for storing the data acquired for multiple times, and the data acquired each time are separately stored.
In one embodiment, the laser module includes:
the light emitting module is used for emitting monochromatic light to irradiate the nasal cavity at the utmost point;
and the control module is used for controlling the power of the emitted monochromatic light.
In one embodiment, the medication administration module comprises:
the pressurizing and conveying module inputs the liquid medicine into a spray head inserted into the nasal cavity through a supercharger;
the atomization module is used for atomizing the sprayed liquid medicine and preventing the nasal cavity from being damaged by overlarge impact force of the liquid medicine.
In one embodiment, the method comprises the following steps:
a processor;
a memory for storing processor-executable instructions;
wherein the processor is configured to:
the nasal discharge in the nasal cavity is detected, so that the data of the nasal cavity environment are obtained, and then the rhinitis state is sent to a processor through an electric signal;
analyzing the sent electric signal, and comparing the electric signal with the rhinitis data to further obtain whether the rhinitis happens or not;
the laser component is controlled to start according to the electric signal, the intensity of monochromatic light emitted by the laser module is controlled according to data obtained by signal comparison, and then the interior of the nasal cavity is irradiated by the emitted light;
and simultaneously controls the drug administration component to input the liquid medicine into the nasal cavity according to the signal.
According to the technical scheme, the method and the device for preventing the recurrence of the rhinitis treatment provided by the invention have the following beneficial effects: through detecting the snivel in the nasal cavity, and then reach the data of nasal cavity environment, then send the rhinitis state to the treater through the signal of telecommunication, analyze the signal of telecommunication that sends as far as possible, compare the signal of telecommunication with rhinitis data, and then whether reach rhinitis and attack, start according to signal control laser part, the intensity of the monochromatic light that the data control laser module sent according to the signal contrast reachs, and then shine through the light that sends to the nasal cavity inside, and then the power that makes laser is directly proportional with the degree of rhinitis, prevent that laser power is great and cause the damage to the nasal cavity.
It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the disclosure.
Drawings
In order to more clearly illustrate the patentable embodiments of the invention, reference will now be made to the appended drawings, which are briefly described as embodiments or as required in the prior art description. In all the drawings, the elements or parts are not necessarily drawn to actual scale.
FIG. 1 is a flow chart of a method for preventing recurrence of rhinitis in accordance with the present invention;
FIG. 2 is a flowchart of step S1 in the method for preventing and treating rhinitis according to the present invention;
FIG. 3 is a flowchart of step S2 in the method for preventing and treating rhinitis according to the present invention;
FIG. 4 is a flowchart of step S3 in the method for preventing and treating rhinitis according to the present invention;
FIG. 5 is a block diagram of an anti-recurrence device for rhinitis treatment according to the present invention;
Detailed Description
Embodiments of the patented technology of the present invention will be described in detail below with reference to the drawings. The following examples are only for illustrating the technical solutions of the present invention more clearly, and therefore are only used as examples, and the protection scope of the present invention is not limited thereby.
Fig. 1 is a flow chart of a rhinitis treatment anti-recurrence method provided by the patent of the invention, and the method is applied to hearing-aid equipment. As shown in fig. 1, the method for preventing relapse of rhinitis treatment provided in this embodiment includes the following steps S1-S2:
in step S1, data of nasal cavity environment is obtained by detecting the nasal discharge in the nasal cavity, and then the rhinitis state is sent to the processor through an electric signal;
in step S2, analyzing the emitted electrical signal, and comparing the electrical signal with the rhinitis data to determine whether rhinitis occurs;
the data detected by translating a plurality of groups of signals sent by the signal generator are obtained, then the average value of the data is calculated by the processor, and then the average value is compared with the data stored in the processor, so that whether the user has rhinitis attack or not is obtained.
In step S3, the laser component is controlled to start according to the electrical signal, the intensity of the monochromatic light emitted by the laser module is controlled according to the data obtained by signal comparison, and the emitted light irradiates the inside of the nasal cavity;
the power controller in the laser module is controlled through the intensity of the rhinitis data, so that the intensity of the laser is controlled;
in step S4, the administration component is controlled to input the liquid medicine into the nasal cavity according to the signal;
the liquid medicine is delivered into the nasal cavity, atomized by the atomizer and sprayed into the nasal cavity, so that the nasal cavity is prevented from being damaged by overlarge liquid medicine pressure.
As shown in fig. 2, in step S1, the analyzing of the electrical signal from the detection module is performed, and the electrical signal is compared with rhinitis data, so as to determine whether rhinitis has occurred, wherein the rhinitis data includes the content of bacteria in rhinorrhea, the amount of rhinorrhea, and the type of human bacteria, and the method includes the following steps S11-S12:
in step S11, the bacteria content in the nasal cavity of the user is obtained, and the intensity of rhinitis is judged according to the bacteria content;
in step S12, the bacterial species in the nasal cavity of the user is obtained, and the type of rhinitis is determined from the bacterial species.
In one embodiment, as shown in fig. 3, in step S2, in one embodiment, the analyzing the emitted electrical signal and comparing the electrical signal with the rhinitis data to determine whether rhinitis has occurred includes the following steps S21-S23:
in step S21, the content and type of the bacteria in the snivel are calculated for a plurality of times;
analyzing and calculating data generated by multiple detections, and determining the intensity and the type of the rhinitis by the content and the type of the bacteria in the rhinorrhea
In step S22, an average of the bacteria content data in the time domains before and after the time domain is obtained;
in step S23, comparing the average value with rhinitis data to determine whether the patient has rhinitis;
the data that the detection reachd many times exist and remove the difference that changes, also can change along with the inside bacterial content of user's breathing nasal cavity, and then need ask the comparatively accurate data of going out of average value.
In one embodiment, as shown in fig. 4, in step S3, the laser unit is controlled to be activated according to the electrical signal, the intensity of the monochromatic light emitted from the laser module is controlled according to the data obtained by comparing the electrical signal, and the emitted light is used to irradiate the inside of the nasal cavity, including the following steps S3-S32:
in step S31, controlling the laser module to start according to the data analyzed by the processor;
in step S32, controlling the power of the laser module according to the severity of rhinitis, and controlling the appropriate laser to stimulate the nasal cavity;
the nasal inflammation is not as intense and requires different stimuli, and excessive stimulation can cause damage to the nasal cavity.
The following are embodiments of the disclosed apparatus that may be used to perform embodiments of the disclosed methods.
Fig. 5 is a block diagram of a rhinitis treatment relapse prevention device provided by the patent of the present invention, which can be implemented as part or all of a hearing aid device by software, hardware or a combination of both. As shown in fig. 5, the apparatus includes:
the detection module is used for acquiring nasal cavity data from nasal discharge in a nasal cavity environment;
the comparison module is used for carrying out comparison analysis on the acquired nasal cavity data and the rhinitis data so as to obtain a conclusion whether the rhinitis of the patient is in attack;
the laser module is used for emitting monochromatic light to stimulate sympathetic nerves and parasympathetic nerves in the nasal cavity, so that blood vessels of nasal mucosa can be contracted and expanded, meanwhile, a fat layer coated on the surface of red blood cells is rapidly peeled off, the permeability of red blood cell membranes is recovered, the red blood cells aggregated into clusters are dispersed, and the oxygen carrying capacity of the red blood cells is greatly improved; simultaneously activating multiple enzyme bodies in blood, and decomposing and ablating redundant fat in the blood; the disease resistance of the organism is improved; improving the toxic state of the organism, and protecting the organism from free radicals and other toxic substances;
and the drug delivery module is used for spraying the liquid medicine into the nasal cavity to repair the nasal mucosa at best.
The above-mentioned device of this disclosure embodiment, through detecting the snivel in the nasal cavity, and then reach the data of nasal cavity environment, then send the rhinitis state to the treater through the signal of telecommunication, analyze the signal of telecommunication as far as possible that sends, compare the signal of telecommunication with rhinitis data, and then whether reachs rhinitis and attack, start according to signal control laser part, the intensity of the monochromatic light that the data control laser module sent that reachs according to the signal contrast, and then shine to the nasal cavity is inside through the light that sends, and then make the power of laser and the degree of rhinitis be directly proportional, prevent that laser power is great and cause the damage to the nasal cavity.
In one embodiment, the detection module includes:
the acquisition module is used for acquiring the bacterial content and the bacterial species of the nasal discharge in the nasal cavity;
and the storage module is used for storing the data acquired for multiple times, and the data acquired each time are separately stored.
In one embodiment, the laser module includes:
the light emitting module is used for emitting monochromatic light to irradiate the nasal cavity at the utmost point;
and the control module is used for controlling the power of the emitted monochromatic light.
In one embodiment, the medication administration module comprises:
the pressurizing and conveying module inputs the liquid medicine into a spray head inserted into the nasal cavity through a supercharger;
the atomization module is used for atomizing the sprayed liquid medicine and preventing the nasal cavity from being damaged by overlarge impact force of the liquid medicine.
With regard to the apparatus in the above-described embodiment, the specific manner in which each module performs the operation has been described in detail in the embodiment related to the method, and will not be elaborated here.
The embodiment of the present disclosure further provides a device for preventing and treating rhinitis, including:
a processor;
a memory for storing processor-executable instructions;
wherein the processor is configured to:
the nasal discharge in the nasal cavity is detected, so that the data of the nasal cavity environment are obtained, and then the rhinitis state is sent to a processor through an electric signal;
analyzing the sent electric signal, and comparing the electric signal with the rhinitis data to further obtain whether the rhinitis happens or not;
the laser component is controlled to start according to the electric signal, the intensity of monochromatic light emitted by the laser module is controlled according to data obtained by signal comparison, and then the interior of the nasal cavity is irradiated by the emitted light;
and simultaneously controls the drug administration component to input the liquid medicine into the nasal cavity according to the signal.
In the description of the present patent application, numerous specific details are set forth. However, it is understood that embodiments of the invention may be practiced without these specific details. In some instances, well-known methods, structures and techniques have not been shown in detail in order not to obscure an understanding of this description.
In the description herein, reference to the description of the term "one embodiment," "some embodiments," "an example," "a specific example," or "some examples," etc., means that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the present patent. In this specification, the schematic representations of the terms used above are not necessarily intended to refer to the same embodiment or example. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples. Moreover, various embodiments or examples and features of different embodiments or examples described in this specification can be combined and combined by one skilled in the art without contradiction
The above examples are only used to illustrate the technical solutions of the present invention, but not to limit the same; although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art will understand that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; the modifications or substitutions do not make the essence of the corresponding technical solution depart from the scope of the technical solutions of the embodiments of the patent of the present invention, and the technical solutions are all covered in the claims and the specification of the patent of the present invention.
Claims (9)
1. A method for preventing relapse of rhinitis treatment is characterized by comprising the following steps:
the nasal discharge in the nasal cavity is detected, so that the data of the nasal cavity environment are obtained, and then the rhinitis state is sent to a processor through an electric signal;
analyzing the sent electric signal, and comparing the electric signal with the rhinitis data to further obtain whether the rhinitis happens or not;
the laser component is controlled to start according to the electric signal, the intensity of monochromatic light emitted by the laser module is controlled according to data obtained by signal comparison, and then the interior of the nasal cavity is irradiated by the emitted light;
and simultaneously controls the drug administration component to input the liquid medicine into the nasal cavity according to the signal.
2. The method as claimed in claim 1, wherein the analyzing the electrical signal from the detecting module, comparing the electrical signal with rhinitis data to determine whether rhinitis has occurred, wherein the rhinitis data includes the content of bacteria in nasal discharge, the amount of nasal discharge and the type of bacteria in human, comprises:
detecting the rhinorrhea through a bacteria detection module so as to obtain the content of specific weight bacteria;
and analyzing the obtained bacteria content data, and analyzing the types of the bacteria in the data.
3. The method as claimed in claim 1, wherein analyzing the electrical signal and comparing the electrical signal with rhinitis data to determine whether rhinitis has occurred comprises:
calculating the content and species of the bacteria in the nasal discharge for a plurality of times;
calculating the average value of the bacterial content data of the previous time domain and the next time domain;
and comparing the average value with rhinitis data to further obtain whether the patient has rhinitis attack.
4. The method as claimed in claim 3, wherein the laser unit is controlled to start according to the electrical signal, the intensity of the monochromatic light emitted from the laser module is controlled according to the data obtained by comparing the electrical signal with the signal, and the emitted light irradiates the inside of the nasal cavity, comprising:
controlling the laser module to start according to the data analyzed by the processor;
the power of the laser module is controlled according to the severity of rhinitis, and the appropriate laser is controlled to stimulate the nasal cavity.
5. A rhinitis treatment anti-relapse device, comprising:
the detection module is used for acquiring nasal cavity data from nasal discharge in a nasal cavity environment;
the comparison module is used for carrying out comparison analysis on the acquired nasal cavity data and the rhinitis data so as to obtain a conclusion whether the rhinitis of the patient is in attack;
the laser module is used for emitting monochromatic light to stimulate sympathetic nerves and parasympathetic nerves in the nasal cavity, so that blood vessels of nasal mucosa can be contracted and expanded, meanwhile, a fat layer coated on the surface of red blood cells is rapidly peeled off, the permeability of red blood cell membranes is recovered, the red blood cells aggregated into clusters are dispersed, and the oxygen carrying capacity of the red blood cells is greatly improved; simultaneously activating multiple enzyme bodies in blood, and decomposing and ablating redundant fat in the blood; the disease resistance of the organism is improved; improving the toxic state of the organism, and protecting the organism from free radicals and other toxic substances;
and the drug delivery module is used for spraying the liquid medicine into the nasal cavity to repair the nasal mucosa at best.
6. The rhinitis treatment relapse prevention device according to claim 5, wherein the detection module comprises:
the acquisition module is used for acquiring the bacterial content and the bacterial species of the nasal discharge in the nasal cavity;
and the storage module is used for storing the data acquired for multiple times, and the data acquired each time are separately stored.
7. The rhinitis treatment anti-relapse device of claim 5, wherein the laser module comprises:
the light emitting module is used for emitting monochromatic light to irradiate the nasal cavity at the utmost point;
and the control module is used for controlling the power of the emitted monochromatic light.
8. The rhinitis treatment anti-relapse device according to claim 5, wherein the drug delivery module comprises:
the pressurizing and conveying module inputs the liquid medicine into a spray head inserted into the nasal cavity through a supercharger;
the atomization module is used for atomizing the sprayed liquid medicine and preventing the nasal cavity from being damaged by overlarge impact force of the liquid medicine.
9. A rhinitis treatment anti-relapse device, comprising:
a processor;
a memory for storing processor-executable instructions;
wherein the processor is configured to:
the nasal discharge in the nasal cavity is detected, so that the data of the nasal cavity environment are obtained, and then the rhinitis state is sent to a processor through an electric signal;
analyzing the sent electric signal, and comparing the electric signal with the rhinitis data to further obtain whether the rhinitis happens or not;
the laser component is controlled to start according to the electric signal, the intensity of monochromatic light emitted by the laser module is controlled according to data obtained by signal comparison, and then the interior of the nasal cavity is irradiated by the emitted light;
and simultaneously controls the drug administration component to input the liquid medicine into the nasal cavity according to the signal.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111034685.8A CN113786562A (en) | 2021-09-04 | 2021-09-04 | Method and device for preventing recurrence of rhinitis treatment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111034685.8A CN113786562A (en) | 2021-09-04 | 2021-09-04 | Method and device for preventing recurrence of rhinitis treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113786562A true CN113786562A (en) | 2021-12-14 |
Family
ID=79182784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111034685.8A Pending CN113786562A (en) | 2021-09-04 | 2021-09-04 | Method and device for preventing recurrence of rhinitis treatment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113786562A (en) |
Citations (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR200380310Y1 (en) * | 2004-11-11 | 2005-03-29 | 주식회사 평창웰빙칠백 | Portable apparatus for curing rhinitis |
| CN101843953A (en) * | 2010-06-17 | 2010-09-29 | 林湘町 | Nasal warmer |
| US20110229583A1 (en) * | 2010-03-17 | 2011-09-22 | David Van Tran | Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid |
| CN202146526U (en) * | 2011-06-03 | 2012-02-22 | 杨正建 | Anti-drop multi-target laser irradiation rhinobyon having massage and ventilation functions |
| CN203043347U (en) * | 2013-02-01 | 2013-07-10 | 孙东海 | Human body multipath laser therapeutic instrument |
| RU2513477C1 (en) * | 2012-12-25 | 2014-04-20 | Марина Александровна Хорольская | Diagnostic technique for allergic rhinitis |
| JP2015019770A (en) * | 2013-07-18 | 2015-02-02 | 国立大学法人徳島大学 | Device for prophylactic treatment of rhinitis |
| KR20160032670A (en) * | 2015-07-27 | 2016-03-24 | 주식회사 디알메디칼 | Rhinitis therapy device and method for operating thereof |
| CN205832146U (en) * | 2016-06-16 | 2016-12-28 | 安徽医科大学第一附属医院 | A kind of attract flushable infrared ray instrument for treating rhinitis |
| US20170266396A1 (en) * | 2016-03-21 | 2017-09-21 | Joseph Feldman | Nasal spray apparatus |
| CN209060116U (en) * | 2018-03-19 | 2019-07-05 | 中山大学附属第三医院（中山大学肝脏病医院） | A kind of therapeutic equipment for acquiring nasal mucus for rhinitis or flu |
| CN110180085A (en) * | 2019-05-30 | 2019-08-30 | 秦皇岛市惠斯安普医学***股份有限公司 | Rhinitis auxiliary Phototherapeutic instrument is penetrated in a kind of direct insertion semiconductor feux rouges |
| CN209771121U (en) * | 2018-12-21 | 2019-12-13 | 康缘爱电子有限公司 | Rhinitis phototherapy instrument |
| KR20200019545A (en) * | 2018-08-14 | 2020-02-24 | 주식회사 메타신 | Rhinitis photo therapeutic device with a nasal probe using low-level laser based on diffusing light technology |
| KR102127903B1 (en) * | 2019-01-29 | 2020-06-29 | 연세대학교 산학협력단 | Biomarker for diagnosing inflammatory respiratory disease |
| CN211132736U (en) * | 2019-09-06 | 2020-07-31 | 武汉光盾科技有限公司 | Rhinitis therapeutic instrument with accomodate function |
| RU2741211C1 (en) * | 2020-07-16 | 2021-01-22 | Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации | Method for differential diagnostics of bacterial rhinosinusitis inflammation forms |
| CN213158995U (en) * | 2020-06-19 | 2021-05-11 | 东莞市嵘丰医疗器械有限公司 | Rhinitis and influenza therapeutic instrument |
-
2021
- 2021-09-04 CN CN202111034685.8A patent/CN113786562A/en active Pending
Patent Citations (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR200380310Y1 (en) * | 2004-11-11 | 2005-03-29 | 주식회사 평창웰빙칠백 | Portable apparatus for curing rhinitis |
| US20110229583A1 (en) * | 2010-03-17 | 2011-09-22 | David Van Tran | Human Medicinal Treatment Typically Using Salt of Peroxymonosulfuric Acid |
| CN101843953A (en) * | 2010-06-17 | 2010-09-29 | 林湘町 | Nasal warmer |
| CN202146526U (en) * | 2011-06-03 | 2012-02-22 | 杨正建 | Anti-drop multi-target laser irradiation rhinobyon having massage and ventilation functions |
| RU2513477C1 (en) * | 2012-12-25 | 2014-04-20 | Марина Александровна Хорольская | Diagnostic technique for allergic rhinitis |
| CN203043347U (en) * | 2013-02-01 | 2013-07-10 | 孙东海 | Human body multipath laser therapeutic instrument |
| JP2015019770A (en) * | 2013-07-18 | 2015-02-02 | 国立大学法人徳島大学 | Device for prophylactic treatment of rhinitis |
| KR20160032670A (en) * | 2015-07-27 | 2016-03-24 | 주식회사 디알메디칼 | Rhinitis therapy device and method for operating thereof |
| US20170266396A1 (en) * | 2016-03-21 | 2017-09-21 | Joseph Feldman | Nasal spray apparatus |
| CN205832146U (en) * | 2016-06-16 | 2016-12-28 | 安徽医科大学第一附属医院 | A kind of attract flushable infrared ray instrument for treating rhinitis |
| CN209060116U (en) * | 2018-03-19 | 2019-07-05 | 中山大学附属第三医院（中山大学肝脏病医院） | A kind of therapeutic equipment for acquiring nasal mucus for rhinitis or flu |
| KR20200019545A (en) * | 2018-08-14 | 2020-02-24 | 주식회사 메타신 | Rhinitis photo therapeutic device with a nasal probe using low-level laser based on diffusing light technology |
| CN209771121U (en) * | 2018-12-21 | 2019-12-13 | 康缘爱电子有限公司 | Rhinitis phototherapy instrument |
| KR102127903B1 (en) * | 2019-01-29 | 2020-06-29 | 연세대학교 산학협력단 | Biomarker for diagnosing inflammatory respiratory disease |
| CN110180085A (en) * | 2019-05-30 | 2019-08-30 | 秦皇岛市惠斯安普医学***股份有限公司 | Rhinitis auxiliary Phototherapeutic instrument is penetrated in a kind of direct insertion semiconductor feux rouges |
| CN211132736U (en) * | 2019-09-06 | 2020-07-31 | 武汉光盾科技有限公司 | Rhinitis therapeutic instrument with accomodate function |
| CN213158995U (en) * | 2020-06-19 | 2021-05-11 | 东莞市嵘丰医疗器械有限公司 | Rhinitis and influenza therapeutic instrument |
| RU2741211C1 (en) * | 2020-07-16 | 2021-01-22 | Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации | Method for differential diagnostics of bacterial rhinosinusitis inflammation forms |
Non-Patent Citations (1)
| Title |
|---|
| 马品仲;马劲峰;张金艳;: "半导体激光在医疗中应用研究", 应用激光, no. 03, pages 971 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | A non-canonical reticular-limbic central auditory pathway via medial septum contributes to fear conditioning | |
| Chang et al. | Single-unit activity in the medial prefrontal cortex during immediate and delayed extinction of fear in rats | |
| Lang et al. | Similar inhibitory processes dominate the responses of cat lateral amygdaloid projection neurons to their various afferents | |
| AU2009221154B2 (en) | An apparatus and method for indicating cardiac output | |
| Carlson et al. | Deep brain stimulation does not silence neurons in subthalamic nucleus in Parkinson's patients | |
| Shiba et al. | Multifunctional laryngeal motoneurons: an intracellular study in the cat | |
| US20130184781A1 (en) | Brain Stimulation for Enhancement of Learning, Motivation, and Memory | |
| WO2005000206A3 (en) | System and method for detecting, diagnosing, and treating cardiovascular disease | |
| US11911611B2 (en) | Method for electroporation controlled by electrical impedence measurements | |
| CN102793973A (en) | Device for treating Parkinson's disease | |
| Yang et al. | Closed-loop transcranial ultrasound stimulation for real-time non-invasive neuromodulation in vivo | |
| KR20190034867A (en) | Neuromimetic stimulating apparatus and method thereof | |
| US9517342B2 (en) | Olfactory implant system | |
| e Silva et al. | The future of psychiatry: brain devices | |
| CN113786562A (en) | Method and device for preventing recurrence of rhinitis treatment | |
| Sachuriga et al. | Neuronal representation of locomotion during motivated behavior in the mouse anterior cingulate cortex | |
| Coelho et al. | Spatial mapping in the rat olfactory bulb by odor and direct electrical stimulation | |
| RU2017129539A (en) | NEUROMODULATION DEVICE | |
| Ehlers et al. | Electrophysiological response to ethanol in P and NP rats | |
| Xie et al. | Phase-locked closed-loop ultrasound stimulation modulates theta and gamma rhythms in the mouse hippocampus | |
| McHail et al. | Hippocampal gamma rhythms during Y‐maze navigation in the juvenile rat | |
| CN113827875A (en) | Laser circulation irradiation method and device for rhinitis instrument | |
| CN113908445A (en) | Method and device for treating rhinitis by converging laser beams | |
| US20240139537A1 (en) | System and Method for Generating Electromagnetic Treatment Protocol Based on Readings of Biophysical Signals | |
| Zeng et al. | Unilateral laryngeal pacing system and its functional evaluation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |